布地奈德福莫特罗治疗重叠综合征疗效观察  

作　　者：刘雪梅[1] 张昌红[1] 刘晓静[1] 

机构地区：[1]北京市石景山医院,100043

出　　处：《浙江临床医学》2017年第2期282-283,共2页Zhejiang Clinical Medical Journal

摘　　要：目的研究布地奈德福莫特罗治疗重叠综合征（ACOS）（支气管哮喘-慢阻肺ACOS）的治疗效果。方法2014年11月至2015年11月确诊为支气管哮喘-慢阻肺ACOS70例患者随机均分为观察组（n=35）和对照组（n=35）。比较两组疗效[肺功能及6min步行距离（6MWD）]情况。结果观察组及对照组治疗后的肺功能及6MWD均优于治疗前，观察组肺功能及6MWD均较对照组改善显著，差异均有统计学意义（P〈0．05）。结论布地奈德福莫特罗能明显改善ACOS（支气管哮喘-慢阻肺ACOS）的肺功能及6MWD，值得推广。Objective To study the clinical effect ofbudesonide and formoterol for treatment of ACOS. Methods 70 patients with diagnosed of ACOS were randomly divided into observation group and control group both with 35 cases each.Lung function and 6 minute walk distance of the 2 groups were compared. Results The lung function and 6 minute walk distance were better after the treatment in both groups, the improvement in the observation was higher than that in the control group. Conclusion Budesonide and formoterolcan effectively improve lung function and 6 minute walk distance for ACOS and is worth of being recommended clinically.

关 键 词：重叠综合征 肺功能 6MIN步行距离 

分 类 号：R562.25[医药卫生—呼吸系统]